Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

CRISPR-Cas9 system for targeting and removing bacterial resistance plasmids and application

A technology of nature and drug resistance, applied in the direction of antibacterial drugs, medical preparations containing active ingredients, pharmaceutical formulations, etc., can solve problems such as drug resistance, and achieve the effect of ensuring the use effect and eliminating bacterial drug resistance.

Active Publication Date: 2017-11-24
INST OF PLA FOR DISEASE CONTROL & PREVENTION
View PDF0 Cites 32 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Based on the problems existing in the prior art, the purpose of the present invention is to provide a CRISPR-Cas9 system that can efficiently remove two super-resistant plasmids, NDM-1 and MCR-1, in bacteria, can sensitize drug-resistant bacteria, and has Selective killing of resistant bacteria to address technical challenges caused by bacterial resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CRISPR-Cas9 system for targeting and removing bacterial resistance plasmids and application
  • CRISPR-Cas9 system for targeting and removing bacterial resistance plasmids and application
  • CRISPR-Cas9 system for targeting and removing bacterial resistance plasmids and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1: Construction and screening of a CRISPR-Cas9 system targeting NDM-1 and MCR-1 drug resistance genes using pCas9 as a carrier

[0043] 1. Design of target sequences

[0044] (1) The design of the NDM-1 target sequence, according to the PAM principle in the design requirements of sgRNA, select the 30bp base sequence upstream of the NGG trinucleotide in the blaNDM-1 sequence as the target sequence, that is, the spacer in the CRISPR sequence sequence, which can be transcribed into sgRNA in bacterial cells.

[0045] A high-efficiency and specific target T1 sequence was screened from the twenty initially designed target sequences: SEQ ID NO: 1 (5'-ACCGCATTAGCCGCTGCATTGATGCTGAGC-3').

[0046] (2) Design of MCR-1 drug resistance gene sequence target

[0047] According to the colistin resistance gene MCR-1 sequence, according to the PAM principle, a 30bp base sequence was selected as the target of the gene, SEQ ID NO.2 (5'-atgccctacagaccgaccaagccgagacca-3').

[0048...

Embodiment 2

[0085] Example 2: CRISPR-Cas9 system targeted removal of NDM-1 drug-resistant plasmids

[0086] The CRISPR-Cas9 system plasmid pCas9-N targeting NDM-1 transformed the drug-resistant bacteria model containing the pNDM-1 plasmid. Compared with the control group pCas9, pCas9-N can efficiently remove the natural large plasmid pNDM-1, and can Eliminate high copy NDM-1 cloning plasmids (see image 3 ). The removal efficiencies are all greater than 99.9%. Figure 4 Confocal scanning photos of the removal effect of NDM-1 recombinant EGFP high-copy plasmid, NDM-1 plasmid contains a gene capable of expressing enhanced green fluorescent protein (EGFP), from Figure 4It can be seen that the efficient clearance of NDM-1 by pCas9-N leads to the extreme reduction or even disappearance of EGFP. Figure 5 is the columnar control graph of the fluorescence intensity of the NDM-1 plasmid clearance rate; Figure 5 It can be seen that after pCas9-N plasmid removal, the fluorescence intensity de...

Embodiment 3

[0087] Example 3: CRISPR-Cas9 system pCas9-NM simultaneously targets and eliminates NDM-1 and MCR-1 drug-resistant plasmids

[0088] The NDM-1 and MCR-1 drug-resistant plasmids were cleared by pCas9-NM respectively, and the drug-resistant plasmids of the two drug-resistant bacterial models transformed with the pCas9-NM plasmid were detected. After shearing by pCas9-NM, both drug-resistant plasmids were eliminated and could not be detected by PCR (see Figure 6 ).

[0089] Detect changes in bacterial antibiotic sensitivity after pCas9-NM action. Etest drug-sensitive paper strip quantitatively detects the MIC value of the NDM-1 drug-resistant bacteria model to imipenem (thiamycin antibiotic with a carbapenem ring). / ml is reduced to 0.38ug / ml (see Figure 7 ).

[0090] The plate method was used to qualitatively analyze the changes in the bacterial drug sensitivity results after the MCR-1 plasmid was cleared by pCas9-NM. On the LB plates containing 0.5ug / ml colistin, there w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a gRNA sequence. The sequence in a CRISPR-Cas9 system is capable of editing a DNA sequence by taking a resistance plasmid specific site in bacteria as a target sequence. The gRNA sequence is shown as SEQ ID NO:1 and / or 2. The invention also discloses the CRISPR-Cas9 system of the gRNA sequence and an application of the CRISPR-Cas9 system in preparing a drug for treating resistant bacterial infection. The CRISPR-Cas9 system provided by the invention is capable of targeting two super resistance genes of NDM-1 and MCR-1, simultaneously eliminating the two resistance genes and guaranteeing the use effect of carbapenms and colistin antibiotics.

Description

technical field [0001] The invention discloses a CRISPR-Cas9 system for targeted removal of bacterial drug-resistant plasmids. Background technique [0002] Worldwide, 700,000 people die each year from bacterial antibiotic resistance, mostly in Asia and Africa. In China, more than 80,000 people die from drug-resistant bacterial infections every year. According to the estimates of the British Antimicrobial Resistance Assessment Committee, if the current situation cannot be improved, by 2050, 10 million people worldwide will suffer from antimicrobial resistance, which is more than the current number of cancer deaths. The problem of bacterial resistance not only seriously affects human health, but also causes economic losses. A recent report by the World Bank and the Food and Agriculture Organization of the United Nations pointed out that if the problem of antibiotic resistance is not solved by 2050, the global annual GDP will drop by about 1.1%-3.8%, which is equivalent to t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/113C12N9/22C12N15/90A61K48/00A61K31/7105A61P31/04
CPCA61K31/7105C12N9/22C12N15/113C12N15/902Y02A50/30
Inventor 宋宏彬邱少富刘鸿博李浩梁媛杨超杰赵荣涛贾雷立李鹏王立贵
Owner INST OF PLA FOR DISEASE CONTROL & PREVENTION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com